Our Xarelto lawyers know all too well that Big Pharma hides important data from the public to protect their most profitable drugs. There are thousands of death and injury claims against Xarelto federal court, where a legal briefing was just filed accusing the manufacturers of misleading editors of one of the world’s most respected medical journals.
Patients injured by Xarelto – a popular blood thinner – are suing its manufacturers, Johnson & Johnson (J&J) and Bayer, because the drug can cause uncontrollable, fatal bleeding. These wrongful death and injury lawsuits accuse the companies of concealing important safety information and failing to test the drug fully before releasing it for sale.
To prove these claims in court, Xarelto lawyers recently pointed to a letter published in the prestigious New England Journal of Medicine (NEJM). The letter was written by Duke University researchers and led to the FDA’s approval of Xarelto in 2011.